Claim: Retatrutide improved kidney filtering speed and reduced protein leakage into urine in trials involving obesity and diabetes patients.
Verdict: Correct (95% confidence)
Explanation: According to a study published on PMC (Tier 1), higher doses of retatrutide were associated with reduced urine albumin-to-creatinine ratio (UACR) in participants with type 2 diabetes and obesity, and with increased estimated glomerular filtration rate (eGFR) in participants with obesity. This finding is supported by DocWire News (Tier 9), which reports that retatrutide reduced UACR by 37% in these populations. ResearchGate (Tier 9) also confirms these effects, noting improvements in kidney param...